Anti-Myeloma Effects of the Selective JAK1 Inhibitor INCB052793 Using a Platform Study Utilizing the Lagκ-1A Multiple Myeloma Xenograft Model

被引：0
|
作者：
Sanchez, Eric
Li, Mingjie
Wang, Cathy S.
Tanenbaum, Edward J.
Patil, Saurabh
Soof, Camilia
Hekmati, Tara
Schlossberg, Remy E.
Yashar, Moryel A.
Porter, Autumn L.
Tang, George Y.
Chen, Haiming
Berenson, James R.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5393
引用
收藏
页数：2
相关论文
共 10 条
  • [1] Anti-Myeloma Effects of the Selective JAK1 Inhibitor INCB052793 in Combination with Active Myeloma Agents In Vitro and In Vivo
    Sanchez, Eric
    Porter, Autumn
    Li, Mingjie
    Wang, Cathy
    Smith, Emily
    Soof, Camilia
    Director, Chelsea
    Tang, George
    Chen, Haiming
    Berenson, James
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E49 - E50
  • [2] The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo
    Sanchez, Eric
    Li, Mingjie
    Patil, Saurabh
    Soof, Camilia M.
    Nosrati, Jason D.
    Schlossberg, Remy E.
    Vidisheva, Aleksandra
    Tanenbaum, Edward J.
    Hekmati, Tara
    Zahab, Brian
    Wang, Cathy
    Tang, George
    Chen, Haiming
    Berenson, James R.
    [J]. ANNALS OF HEMATOLOGY, 2019, 98 (03) : 691 - 703
  • [3] The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo
    Eric Sanchez
    Mingjie Li
    Saurabh Patil
    Camilia M. Soof
    Jason D. Nosrati
    Remy E. Schlossberg
    Aleksandra Vidisheva
    Edward J. Tanenbaum
    Tara Hekmati
    Brian Zahab
    Cathy Wang
    George Tang
    Haiming Chen
    James R. Berenson
    [J]. Annals of Hematology, 2019, 98 : 691 - 703
  • [4] Effects of INCB052793, a Selective JAK1 Inhibitor, in Combination with Anti- Myeloma Agents on Human Multiple Myeloma (MM) In Vitro and In Vivo
    Sanchez, Eric
    Li, Mingjie
    Wang, Cathy S.
    Mehta, Puja
    Tang, George
    Chen, Haiming
    Berenson, James
    [J]. BLOOD, 2016, 128 (22)
  • [5] Effects of INCB052793, a selective JAK1 inhibitor, in combination with standard of care agents in human multiple myeloma (MM) cell lines and xenograft models
    Sanchez, Eric
    Li, Mingjie
    Wang, Cathy
    Mehta, Puja
    Tang, George
    Chen, Haiming
    Berenson, James R.
    [J]. CANCER RESEARCH, 2016, 76
  • [6] The BET inhibitor INCB054329 is synergistic with JAK1 inhibition in models of multiple myeloma
    Stubbs, Matthew C.
    Liu, Xuesong M.
    Wen, Xiaoming
    Li, Jun
    Dostalik, Valerie
    O'Connor, Sybil
    Caulder, Eian
    Favata, Margaret
    Rupar, Mark
    Li, Yu
    Rumberger, Beth
    Maduskuie, Thomas
    Sparks, Richard
    Falahatpisheh, Nikoo
    Polam, Padmaja
    Vaddi, Kris
    Burn, Timothy
    Combs, Andrew P.
    Yao, Wenqing
    Huber, Reid
    Hollis, Gregory
    Scherle, Peggy
    Liu, Phillip C. C.
    [J]. CANCER RESEARCH, 2015, 75
  • [7] A Phase 1/2 Study of the Oral Novel JAK1 Inhibitor INCB052793 As Monotherapy and in Combination with Standard Therapies in Patients with Advanced Hematologic Malignancies
    Zeidan, Amer M.
    Cook, Rachel J.
    Bordoni, Rodolfo
    Asatiani, Ekaterine
    Zhou, Gongfu
    Faivre, Thea
    Byrne, Michael
    Savona, Michael R.
    [J]. BLOOD, 2017, 130
  • [8] INCB052793, a JAK1 selective inhibitor, is highly efficacious in PDX and xenograft models of acute myeloid leukemia (AML) expressing elevated endogenous pSTAT3/pSTAT5
    Juvekar, Ashish
    Condon, Sindy
    Wen, Xiaoming
    Ruggeri, Bruce
    Scherle, Peggy
    Huber, Reid
    Li, Yunlong
    Yao, Wenqing
    Mei, Song
    Bhasin, Deepak
    Mancini, Maria
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [9] INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support
    Li, Jun
    Favata, Margaret
    Kelley, Jennifer A.
    Caulder, Eian
    Thomas, Beth
    Wen, Xiaoming
    Sparks, Richard B.
    Arvanitis, Ari
    Rogers, James D.
    Combs, Andrew P.
    Vaddi, Kris
    Solomon, Kimberly A.
    Scherle, Peggy
    Newton, Robert
    Fridman, Jordan S.
    [J]. NEOPLASIA, 2010, 12 (01): : 28 - 38
  • [10] The humanized Anti-CD40 antibody SGN-40 inhibits tumor growth in LAGκ-1A, a CD40+ mouse model of human multiple myeloma.
    Campbell, Richard A.
    Gordon, Melinda S.
    Sanchez, Eric
    Chen, Haiming
    Turker, Lauren
    Trac, Olivia
    Li, Mingjie
    Pang, Shen
    Bonavida, Benjamin.
    Said, Jonathan
    Drachman, Jonathan G.
    Berenson, James R.
    [J]. BLOOD, 2006, 108 (11) : 1000A - 1000A
1